| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |